Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001127855-13-000351
Filing Date
2013-05-16
Accepted
2013-05-16 16:15:57
Documents
11
Period of Report
2012-08-31

Document Format Files

Seq Description Document Type Size
1 NAPRODIS 10K, 08.31.12 naprodis10k083112.htm 10-K 777496
2 NAPRODIS 10K, AUDITORS LETTER naprodisexh16.htm EX-16 5156
3 NAPRODIS 10K, CERTIFICATION 302 naprodisexh31.htm EX-31 19605
4 NAPRODIS 10K, CERTIFICATION 906 naprodisexh32.htm EX-32 5402
5 NAPRODIS 10K, GRAPHIC 1 antonchia_logo.jpg GRAPHIC 12784
  Complete submission text file 0001127855-13-000351.txt   2950399

Data Files

Seq Description Document Type Size
6 napr-20120831_cal.xml EX-101.CAL 18740
7 napr-20120831_def.xml EX-101.DEF 12111
8 napr-20120831.xml EX-101.INS 517438
9 napr-20120831_lab.xml EX-101.LAB 75038
10 napr-20120831_pre.xml EX-101.PRE 59403
11 napr-20120831.xsd EX-101.SCH 9260
Mailing Address 13250 GREGG STREET SUITE F POWAY CA 92064
Business Address 13250 GREGG STREET SUITE F POWAY CA 92064 (858) 486-8655
Naprodis, Inc. (Filer) CIK: 0001313938 (see all company filings)

EIN.: 330903494 | State of Incorp.: NV | Fiscal Year End: 0831
Type: 10-K | Act: 34 | File No.: 333-122009 | Film No.: 13851452
SIC: 2834 Pharmaceutical Preparations